Paper · 6283358
Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus.
Chang EH and 3 others. Nature, 1982. Cited by 603 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus. Papers, record 6283358. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6283358
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Transformation, Neoplastic | Major topic |
| Genes | Major topic |
| Genes, Viral | Major topic |
| Sarcoma Viruses, Murine | Major topic |
| Animals | |
| Cell Line | |
| Cells, Cultured | |
| DNA Restriction Enzymes | |
| DNA, Recombinant | |
| Humans | |
| Kirsten murine sarcoma virus | |
| Mice | |
| Nucleic Acid Hybridization | |
| Rats | |
| Species Specificity |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by164
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 603 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,229,267 | A novel carcinogenic mouse model by site-directed insertion of tandem human HRAS large DNA fragment into 15E1 site. | Animal Model Exp Med | 2025 | https://conductscience.org/library/papers/41229267 | PubMed |
| 40,268,809 | Efficacy of CRISPR-Cas9 gene editing for targeting KRAS mutations in pancreatic cancer: a systematic review. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40268809 | PubMed |
| 39,367,162 | KRAS mutations detection methodology: from RFLP to CRISPR/Cas based methods. | Funct Integr Genomics | 2024 | https://conductscience.org/library/papers/39367162 | PubMed |
| 37,964,407 | Oncogenic KRAS, Mucin 4, and Activin A-Mediated Fibroblast Activation Cooperate for PanIN Initiation. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/37964407 | PubMed |
| 36,077,614 | DNA Polymerase Theta Plays a Critical Role in Pancreatic Cancer Development and Metastasis. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36077614 | PubMed |
| 32,493,501 | Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells. | J Exp Clin Cancer Res | 2020 | https://conductscience.org/library/papers/32493501 | PubMed |
| 27,340,238 | Oncogenic KRAS and BRAF Drive Metabolic Reprogramming in Colorectal Cancer. | Mol Cell Proteomics | 2016 | https://conductscience.org/library/papers/27340238 | PubMed |
| 26,284,568 | MicroRNA-Based Therapeutic Strategies for Targeting Mutant and Wild Type RAS in Cancer. | Drug Dev Res | 2015 | https://conductscience.org/library/papers/26284568 | PubMed |
| 26,070,366 | Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas. | Cell Stress Chaperones | 2015 | https://conductscience.org/library/papers/26070366 | PubMed |
| 25,621,172 | Putting the pieces together: How is the mitochondrial pathway of apoptosis regulated in cancer and chemotherapy? | Cancer Metab | 2014 | https://conductscience.org/library/papers/25621172 | PubMed |
1 to 10 of 164
See all 164 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HRAS | 3,265 | PubTator's text mining | https://conductscience.org/library/genes/3265 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6283358
GET https://conductscience.org/api/papers/v1/6283358/cited_by?page=2